Benefits and Risks of Screening Mammography in Women With BRCA1 and BRCA2 Mutations

JAMA: The Journal of the American Medical Association

Volumn 278, Issue 4, 1997, Pages 290-

  Vaidya, Jayant S ^a   Baum, Michael ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA2 PROTEIN; TRANSCRIPTION FACTOR; TUMOR PROTEIN;

BREAST TUMOR; FEMALE; GENETICS; HUMAN; MAMMOGRAPHY; MUTATION; NOTE; RISK; TUMOR SUPPRESSOR GENE;

BRCA2 PROTEIN; BREAST NEOPLASMS; FEMALE; GENES, BRCA1; HUMANS; MAMMOGRAPHY; MUTATION; NEOPLASM PROTEINS; RISK; TRANSCRIPTION FACTORS;

EID: 0031584440     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1997.03550040046030     Document Type: Letter

References (4)

1. Burke W, Daly M, Garber J, et al, for the Cancer Genetics Studies Consortium. Recommendations for follow-up care of individuals with an inherited predisposition to cancer, II: BRCA1 and BRCA2. JAMA. 1997;277:997-1003.
2. Milner J, Ponder B, Hughes-Davies L, Seltmann M, Kouzarides T. Transcriptional activation functions in BRCA2 Nature. 1997;386:772-773.
3. Sharan SK, Morimatsu M, Albrecht U, et al. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature. 1997;386:804-810.
4. Kinzler KW, Vogelstein B. Gatekeepers and caretakers. Nature. 1997;386:761-763.